imipramine has been researched along with brimonidine tartrate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Healy, D; Horton, RW; Kerry, SM; Lawrence, KM; Paykel, ES; Theodorou, AE; White, W; Whitehouse, AM; Wilton-Cox, H | 1 |
| Duman, RS; Enna, SJ; Nomura, S | 1 |
2 other study(ies) available for imipramine and brimonidine tartrate
| Article | Year |
|---|---|
Platelet alpha 2-adrenoceptors, defined with agonist and antagonist ligands, in depressed patients, prior to and following treatment.
Topics: Adrenergic alpha-Agonists; Binding, Competitive; Blood Platelets; Brimonidine Tartrate; Depressive Disorder; Electroconvulsive Therapy; Humans; Imipramine; Lofepramine; Psychiatric Status Rating Scales; Quinoxalines; Radioligand Assay; Receptors, Adrenergic; Yohimbine | 1991 |
In vivo or in vitro exposure to imipramine reduces alpha 2-adrenoceptor-mediated inhibition of cyclic AMP production in rat brain cerebral cortical slices.
Topics: Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Cerebral Cortex; Colforsin; Cyclic AMP; Drug Interactions; Imipramine; Male; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1987 |